Beta Bionics Inc (BBNX)

R&D to Revenue

31.99%

Quarterly · Period ending:

BBNX logo

BBNX R&D to Revenue

Latest reported31.99%
BBNX Quarterly R&D/Revenue (124.60% → 31.99%)
High-resolution chart · PNG

BBNX r&d to revenue history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Beta Bionics Inc R&D to Revenue — Quarterly
Period endingR&D to Revenue
31.987%
37.4864%
31.5401%
30.0701%
38.1831%
43.0297%
45.0783%
30.7752%
42.2039%
42.3645%
53.4132%
124.6039%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.